Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Huaxia Pharmaceutical is a well-established pharmaceutical company based in Shanghai, China, and operates as a subsidiary of the state-owned giant Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company specializes in the development, manufacturing, and commercialization of a wide range of chemical drugs and traditional Chinese medicines (TCM), with a strong focus on therapeutic areas such as cardiovascular health, digestive system disorders, and general wellness. Its product portfolio includes well-known over-the-counter (OTC) and prescription medications, notably its 'Huaxia' brand analgesics and anti-inflammatory products. Leveraging its integration within the SPH network, Shanghai Huaxia Pharmaceutical maintains high-standard manufacturing facilities and a robust distribution network across Mainland China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Huaxia.